private:spinethera
|
3309076
|
Dec 3rd, 2020 12:00AM
|
SpineThera
|
175
|
8.00
|
Open
|
Pharmaceuticals
|
Dec 3rd, 2020 01:14PM
|
Dec 3rd, 2020 01:14PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Dec 2nd, 2020 12:00AM
|
SpineThera
|
175
|
8.00
|
Open
|
Pharmaceuticals
|
Dec 2nd, 2020 04:27PM
|
Dec 2nd, 2020 04:27PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Dec 1st, 2020 12:00AM
|
SpineThera
|
175
|
8.00
|
Open
|
Pharmaceuticals
|
Dec 1st, 2020 02:55PM
|
Dec 1st, 2020 02:55PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 30th, 2020 12:00AM
|
SpineThera
|
175
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 29th, 2020 08:57PM
|
Nov 30th, 2020 03:46PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 28th, 2020 12:00AM
|
SpineThera
|
175
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 28th, 2020 04:32PM
|
Nov 28th, 2020 04:32PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 27th, 2020 12:00AM
|
SpineThera
|
174
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 27th, 2020 12:58PM
|
Nov 27th, 2020 12:58PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 26th, 2020 12:00AM
|
SpineThera
|
174
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 25th, 2020 07:50PM
|
Nov 26th, 2020 01:56PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 24th, 2020 12:00AM
|
SpineThera
|
174
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 24th, 2020 03:15PM
|
Nov 24th, 2020 03:15PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 23rd, 2020 12:00AM
|
SpineThera
|
174
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 23rd, 2020 05:12PM
|
Nov 23rd, 2020 05:12PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|
private:spinethera
|
3309076
|
Nov 22nd, 2020 12:00AM
|
SpineThera
|
174
|
8.00
|
Open
|
Pharmaceuticals
|
Nov 22nd, 2020 04:08PM
|
Nov 22nd, 2020 04:08PM
|
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
|
Open
|
|
Open
|
|
|
|
|
|
|
SpineThera
|
|
Pharmaceuticals & Biotechnology
|